HBIO Harvard Bioscience Inc

Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing.

$8.02  -0.13 (-1.60%)
As of 07/26/2021 09:56:04 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  39,956,714
Average volume:  201,610
Market cap:   $321,651,548
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    416906105
ISIN:        US4169061052
Sedol:      2694995
Valuation   (See tab for details)
PE ratio:   -82.17
PB ratio:   4.22
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy